Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet β-cells

Diabetes

Volumn 60, Issue 9, 2011, Pages 2315-2324

  Dezaki, Katsuya ^a   Damdindorj, Boldbaatar ^a   Sone, Hideyuki ^a   Dyachok, Oleg ^b   Tengholm, Anders ^b   Gylfe, Erik ^b   Kurashina, Tomoyuki ^a   Yoshida, Masashi ^a   Kakei, Masafumi ^a   Yada, Toshihiko ^a,c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GHRELIN; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HORMONAL REGULATION; INSULIN RELEASE; MALE; MICROFLUOROMETRY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GHRELIN; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 80052878624     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0368     Document Type: Article

References (50)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660 (Pubitemid 129516334)
2. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977 (Pubitemid 26275178)
3. Kojima M, Kangawa K. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat Clin Pract Endocrinol Metab 2006;2:80-88 (Pubitemid 44446932)
4. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988-2991 (Pubitemid 34655375)
5. 2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 2004;53:3142-3151
6. Kageyama H, Funahashi H, Hirayama M, et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005;126:67-71 (Pubitemid 40037745)
7. Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008;105:6320-6325 (Pubitemid 351758344)
8. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008;132:387-396 (Pubitemid 351192001)
9. An W, Li Y, Xu G, et al. Modulation of ghrelin O-acyltransferase expression in pancreatic islets. Cell Physiol Biochem 2010;26:707-716
10. Reimer MK, Pacini G, Ahrén B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003;144:916-921 (Pubitemid 36262858)
11. Tong J, Prigeon RL, Davis HW, et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 2010;59:2145-2151
12. Dezaki K, Sone H, Koizumi M, et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006;55:3486-3493 (Pubitemid 44923609)
13. Yada T, Dezaki K, Sone H, et al. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 2008;4:18-23 (Pubitemid 351210968)
14. Dezaki K, Sone H, Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 2008;118:239-249
15. 2+ signaling and insulin release in islet β-cells: novel signal transduction of ghrelin. Diabetes 2007;56:2319-2327
16. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000;49:1751-1760
17. Prentki M, Matschinsky FM. Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 1987;67: 1185-1248 (Pubitemid 18003171)
18. Dyachok O, Idevall-Hagren O, Sågetorp J, et al. Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab 2008;8:26-37 (Pubitemid 351859229)
19. Dyachok O, Isakov Y, Sågetorp J, Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting b-cells. Nature 2006;439:349-352 (Pubitemid 43128861)
20. 2+ signaling in rat islet β-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide. J Pharmacol Exp Ther 2001;296:22-30
21. Higashi H, Sato K, Ohtake A, Omori A, Yoshida S, Kudo Y. Imaging of cAMP-dependent protein kinase activity in living neural cells using a novel fluorescent substrate. FEBS Lett 1997;414:55-60 (Pubitemid 27380354)
22. MacDonald PE, Wheeler MB. Voltage-dependent K+ channels in pancreatic β cells: role, regulation and potential as therapeutic targets. Diabetologia 2003;46:1046-1062 (Pubitemid 37041235)
23. Christensen AE, Selheim F, de Rooij J, et al. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 2003;278:35394-35402 (Pubitemid 37102308)
24. Enserink JM, Christensen AE, de Rooij J, et al. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002;4:901-906 (Pubitemid 35331366)
25. Bubis J, Neitzel JJ, Saraswat LD, Taylor SS. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase. J Biol Chem 1988;263:9668-9673
26. Ringheim GE, Taylor SS. Effects of cAMP-binding site mutations on intra-domain cross-communication in the regulatory subunit of cAMP-dependent protein kinase I. J Biol Chem 1990;265:19472-19478 (Pubitemid 120013888)
27. de Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 2000;275:20829-20836 (Pubitemid 30457676)
28. Chepurny OG, Kelley GG, Dzhura I, et al. PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2′-O-Me- cAMP-AM in human islets of Langerhans. Am J Physiol Endocrinol Metab 2010;298:E622-E633
29. Drucker DJ. Glucagon-like peptides. Diabetes 1998;47:159-169 (Pubitemid 28079969)
30. Gremlich S, Porret A, Hani EH, et al. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 1995;44:1202-1208
31. Klinteberg KA, Karlsson S, Ahrén B. Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells. Endocrinology 1996;137:2791-2798 (Pubitemid 26192172)
32. + currents by exendin 4 requires dual activation of the cAMP/ protein kinase A and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 2003;278:52446-52453
33. + channels in insulin-secreting cells via a pertussis toxin-sensitive G-protein. EMBO J 1989;8:413-420
34. Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol 1996;271:C1781-C1799
35. Wang Y, Park S, Bajpayee NS, et al. Augmented glucose-induced insulin release in mice lacking Go2, but not Go1 or Gi proteins. Proc Natl Acad Sci USA 2011;108:1693-1698
36. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002;146:241-244 (Pubitemid 34162918)
37. Henquin JC, Nenquin M. The muscarinic receptor subtype in mouse pancreatic B-cells. FEBS Lett 1988;236:89-92
38. Gautam D, Han SJ, Hamdan FF, et al. A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 2006;3:449-461 (Pubitemid 43811775)
39. 2+ for acetylcholine stimulation of insulin release in mouse islets. Diabetes 1989;38:198-204
40. 2+ origin. J Physiol 1995;488:13-24
41. Glavaski-Joksimovic A, Jeftinija K, Scanes CG, Anderson LL, Jeftinija S. Stimulatory effect of ghrelin on isolated porcine somatotropes. Neuroendocrinology 2003;77:367-379 (Pubitemid 36831201)
42. Malagón MM, Luque RM, Ruiz-Guerrero E, et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 2003;144:5372-5380 (Pubitemid 37476066)
43. Mladenov MI, Hristov KL, Dimitrova DZ, et al. Ghrelin signalling in guinea-pig femoral artery smooth muscle cells. Acta Physiol (Oxf) 2008;194:195-206
44. Hermans E. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther 2003;99:25-44 (Pubitemid 36694748)
45. Geelissen SM, Beck IM, Darras VM, Kühn ER, Van der Geyten S. Distribution and regulation of chicken growth hormone secretagogue receptor isoforms. Gen Comp Endocrinol 2003;134:167-174 (Pubitemid 37153124)
46. Kineman RD, Gahete MD, Luque RM. Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. J Mol Endocrinol 2007;38:511-521 (Pubitemid 47019056)
47. Jiang H, Betancourt L, Smith RG. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 2006;20:1772-1785 (Pubitemid 44148083)
48. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006;3:379-386
49. Esler WP, Rudolph J, Claus TH, et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 2007;148:5175-5185 (Pubitemid 350012622)
50. Barnett BP, Hwang Y, Taylor MS, et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010;330:1689-1692